Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 295

1.

Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial.

Douketis JD, Murphy SA, Antman EM, Grip LT, Mercuri MF, Ruff CT, Weitz JI, Braunwald E, Giugliano RP.

Thromb Haemost. 2018 May 3. doi: 10.1055/s-0038-1645856. [Epub ahead of print]

PMID:
29723874
2.

Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Diendéré G, Piché A, Filion KB, Klil-Drori AJ, Douketis JD, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3. Review.

PMID:
29687454
3.

An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants.

Godin R, Roy G, Douketis J.

Thromb Res. 2018 May;165:14-17. doi: 10.1016/j.thromres.2018.03.004. Epub 2018 Mar 8. Review.

PMID:
29549777
4.

A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Leblanc K, Semchuk WM, Papastergiou J, Snow B, Mandlsohn L, Kapoor V, Guirguis LM, Douketis JD, Geerts W, Gladstone DJ.

Can Pharm J (Ott). 2018 Feb 9;151(2):102-106. doi: 10.1177/1715163518756926. eCollection 2018 Mar-Apr. No abstract available.

5.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Bhagirath V, Liaw PC, Weitz JI, Julian JA.

Blood. 2018 May 10;131(19):2151-2160. doi: 10.1182/blood-2017-09-805689. Epub 2018 Feb 28.

PMID:
29490924
6.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel.

Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19.

PMID:
29475527
7.

Reversal agents for non-vitamin K antagonist oral anticoagulants.

Levy JH, Douketis J, Weitz JI.

Nat Rev Cardiol. 2018 May;15(5):273-281. doi: 10.1038/nrcardio.2017.223. Epub 2018 Jan 18. Review.

PMID:
29345686
8.

Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial.

Clark NP, Douketis JD, Hasselblad V, Schulman S, Kindzelski AL, Ortel TL; BRIDGE Investigators.

Am Heart J. 2018 Jan;195:108-114. doi: 10.1016/j.ahj.2017.09.015. Epub 2017 Sep 21.

PMID:
29224638
9.

Perioperative management of anticoagulant and antiplatelet therapy.

Tafur A, Douketis J.

Heart. 2017 Dec 7. pii: heartjnl-2016-310581. doi: 10.1136/heartjnl-2016-310581. [Epub ahead of print] No abstract available.

PMID:
29217632
10.

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.

Douketis JD, Spyropoulos AC, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M, Dentali F, Duncan J, Gross PL, Kassis J, Kowalski S, Lee AY, Le Gal G, Le Templier G, Li N, MacKay E, Shah V, Shivakumar S, Solymoss S, Spencer FA, Syed S, Tafur AJ, Vanassche T, Thiele T, Wu C, Yeo E, Schulman S.

Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6.

PMID:
29212129
11.

Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C; ATTRACT Trial Investigators.

N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.

PMID:
29211671
12.

Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.

Wein T, Lindsay MP, Côté R, Foley N, Berlingieri J, Bhogal S, Bourgoin A, Buck BH, Cox J, Davidson D, Dowlatshahi D, Douketis J, Falconer J, Field T, Gioia L, Gubitz G, Habert J, Jaspers S, Lum C, McNamara Morse D, Pageau P, Rafay M, Rodgerson A, Semchuk B, Sharma M, Shoamanesh A, Tamayo A, Smitko E, Gladstone DJ; Heart and Stroke Foundation Canadian Stroke Best Practice Committees.

Int J Stroke. 2018 Jun;13(4):420-443. doi: 10.1177/1747493017743062. Epub 2017 Nov 24.

PMID:
29171361
13.

Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm.

Riva N, Camporese G, Iotti M, Bucherini E, Righini M, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P, Ageno W; PALLADIO Study Investigators.

J Thromb Haemost. 2018 Feb;16(2):271-278. doi: 10.1111/jth.13905. Epub 2017 Dec 8.

PMID:
29125695
14.

Navigating the anticoagulant landscape in 2017.

Douketis JD.

Cleve Clin J Med. 2017 Oct;84(10):768-778. doi: 10.3949/ccjm.84gr.17005. Review.

15.

Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.

Essebag V, Proietti R, Birnie DH, Wang J, Douketis J, Coutu B, Parkash R, Lip GYH, Hohnloser SH, Moriarty A, Oldgren J, Connolly SJ, Ezekowitz M, Healey JS.

Europace. 2017 Oct 1;19(10):1630-1636. doi: 10.1093/europace/euw409.

PMID:
28339794
16.

Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey.

Agzarian J, Linkins LA, Schneider L, Hanna WC, Finley CJ, Schieman C, De Perrot M, Crowther M, Douketis J, Shargall Y.

J Thorac Dis. 2017 Jan;9(1):80-87. doi: 10.21037/jtd.2017.01.38.

17.

Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.

Coyle K, Carrier M, Lazo-Langner A, Shivakumar S, Zarychanski R, Tagalakis V, Solymoss S, Routhier N, Douketis J, Coyle D.

Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.

PMID:
28160670
18.

Managing challenging patients with venous thromboembolism: a practical, case-based approach.

Douketis J, Ageno W, Carrier M, Kearon C.

Pol Arch Intern Med. 2017 Jan 4;127(1):41-46. doi: 10.20452/pamw.3879. Epub 2017 Jan 4. Review.

19.

Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials.

Liew AY, Piran S, Eikelboom JW, Douketis JD.

J Thromb Thrombolysis. 2017 Apr;43(3):291-301. doi: 10.1007/s11239-016-1461-1. Review.

PMID:
27900627
20.

Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2.

Douketis J, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):801-802. doi: 10.20452/pamw.3610. Epub 2016 Oct 28. No abstract available.

Supplemental Content

Loading ...
Support Center